Notat vedrørende forslag til ny transportordning for blodprøver fra praktiserende læger i det tidligere Fyns Amt.

Notat vedrørende forslag til ny transportordning for blodprøver fra praktiserende læger i det tidligere Fyns Amt. 1. Indledning. Sygehusene varetager en meget stor del af de praktiserende lægers behov for laboratorieundersøgelser. I den forbindelse indsender de praktiserende læger blodprøver og rekvisitioner til sygehuslaboratorierne. Disse blodprøver håndteres og transporteres på forskellig vis rundt om i regionen. Der findes mange forskellige metoder for transport af blodprøverne til sygehusene, f. eks. via postforsendelse, transport med rutebiler opsamling af sygehusbiler etc. Dette notat beskriver de nuværende transportordninger på Fyn og forslag til ny transportordning. Baggrunden for notatet er nyligt gennemførte undersøgelser, som påviser, at kvaliteten i dele af transportordningen på Fyn ikke er tilfredsstillende, jfr. vedlagte videnskabelige artikel (bilag 1). Dette gælder især transporten på Fyn med rutebil. Den videnskabelige artikel har været forelagt regionens laboratoriegruppe på møderne 22. februar og 23. marts 2007. Der er derfor behov for at beskrive og analysere forskellige metoder til at håndtere transporten af blodprøver fra almen praksis og til sygehuslaboratorierne på Fyn. Transporten af blodprøver er imidlertid kun en del af den præanalytiske proces for blodprøver, hvorfor der i notatet tillige inddrages problemstillinger omkring håndtering af blodprøverne i almen praksis og omkring håndtering af blodprøverne i laboratorierne. 2. De nuværende transportordninger på Fyn. Den nuværende transportordning på Fyn dækker over en række forskellige ordninger: Page 1 of 28

Aflevering af ucentrifugerede prøver i postkasser til afhentning via rutebiler omfatter en række landpraksis (ca. 54 praksis). I Odense (ca. 70 praksis) henter sygehusportør ucentrifugerede prøver på to opsamlingssteder i centrum samt hos en række praksis uden for centrum. Afhentes kl. 12 senest. I Svendborg afhenter portørbil og apoteksbil ucentrifugerede prøver i alle praksis (18 praksis). I Fåborg afhenter portør ucentrifugerede prøver i 6 praksis ud af 7. I Middelfart og Strib afhentes ucentrifugerede prøver i 3 praksis. På ruter mellem nogle af amtets sygehuse afhenter sygehusbiler ucentrifugerede prøver hos ca. 12 praksis. Udgifterne til de bestående ordninger udgør i alt ca. 1,5 mio. kr. Heraf udgør udgiften til Fyn-Bus, ca. 560.000 kr., Porto og forsendelse af prøveglas etc., ca. 550.000 kr. Utensilier, ca. 300.000 kr. Emballage til transport, 367.000 kr. Sygehusbiler indgår i ordningen med en skønnet årlig udgift på 248.000 kr. Chaufførerne indgår fra sygehusportørcentralerne (OUH) med 2 timer dagligt til afhentning af prøver fra depot og rutebilordning. Øvrig kørsel er ikke beregnet. Depotets medarbejdere anvender 1.155 timer årligt, svarende til ca. 250.000 kr./år. De praktiserende læger betaler et årligt bidrag på 350 kr. pr. læge og 750 kr. pr. ydernummer til drift af ordningen. I alt udgør medfinansieringen ca. 250.000 kr. Rutebiltransporten giver anledning til kvalitetsmæssige problemer. Dette skyldes at blodprøverne udsættes for ekstreme temperaturpåvirkninger samt rystelse. Hertil kommer, at rutebilchaufførerne af og til glemmer at hente prøverne i postkasserne ved stoppestederne. Page 2 of 28

3. Mulige andre ordninger. Til afløsning for de nuværende ordninger er der opstillet nogle modeller, som selvfølgelig kan kombineres. Som et element i vurderingen af de forskellige ordninger er der bl.a. inddraget på hvilke tidspunkter, prøverne er blevet taget i Vejle Amt for praksis, der er omfattet af henteordning. Tabel 1. Tidspunkt for blodprøvetagning (ydelse 2101) i Vejle Amt, marts maj 2006. Ydelse 2101 Klokkeslet Antal Pct. Kumuleret. antal Pct. 7-8 123 0,4% 123 0,4% 8-9 3.113 10,8% 3.236 11,3% 9-10 5.749 20,0% 8.985 31,3% 10-11 5.566 19,4% 14.551 50,6% 11-12 4.936 17,2% 19.487 67,8% 12-13 2.553 8,9% 22.040 76,7% 13-14 2.649 9,2% 24.689 85,9% 14-15 2.006 7,0% 26.695 92,9% 15-16 1.031 3,6% 27.726 96,5% 16-17 523 1,8% 28.249 98,3% 17-18 384 1,3% 28.633 99,6% 18-19 104 0,4% 28.737 100,0% I alt 28.737 100,0% Det ses af tabellen, at ca. 7 pct. af prøverne tages efter det gennemsnitlige afhentningstidspunkt, som er ca. kl. 15 i afhentningstidsrummet kl. 14 16. Nedenfor er der opstillet en oversigt over den samlede økonomi i de forskellige mulige transportordninger. I bilag 2 indgår Portørtjenestens beregninger over udgifter til biler og chauffører og i bilag 3 indgår sygehuslaboratoriernes overslag over følgeudgifter på sygehuslaboratoriet som følge af omlægningerne.. 3.1. Rammeaftale om blodprøvetagning Indgåelse af rammeaftale om blodprøvetagning fra åre inkl. centrifugering og præparation er en mulighed ifølge landsoverenskomsten, hvor prisen er 96,52 pr. ydelse 2601 imod 48,26 kr. pr. ydelse 2101. Meromkostningen ved at indføre ydelse 2601 på Fyn er skønsmæssigt beregnet til årligt at udgøre ca. 14,0 mio. kr. i forhold til den nuværende afregning med lægerne for blodprøvetagning, ydelse 2101. Page 3 of 28

Udgift til ny emballage 367.000 kr. Alle utensilier, bl.a. tom emballage fra sygehuslaboratorium til brug ved prøvetagning postforsendes til praksis. Udgiften hertil beløber sig til 0,5 mio. kr. Rammeaftale om centrifugering af blodprøver er indgået i Sønderjyllands Amt, Ribe Amt og for enkelte landpraksis i Vejle Amt. Fordele ved denne ordning er, at tilstrækkelig kvalitet kan opnås ved afpipettering af prøverne i praksis efter centrifugering af prøverne og at samtlige blodprøver taget i praksis kan omfattes af ordningen. Ordningen er økonomisk fordelagtig for praksis - selvom prøverne skal afpipetteres og praksis skal anskaffe centrifuger. Ulemperne knytter sig til håndteringen af prøverne i praksis med tidsforbruget og med forbytnings- eller smitterisiko. Hertil kommer, at forbytningsrisikoen i praksis er betydelig (ca. 5 pct.), viser Fyns og Vejle amters fælles undersøgelse. Hertil kommer vanskeligere og mere tidskrævende håndtering på sygehuset ved åbning af emballagen på sygehuset og ved overflytning til racks til centrifugeringen. Endelig skal det nævnes, at der samlet set er tale om en forholdsvis høj merudgift for regionen, skønsmæssigt i alt ca. 12,5 mio. kr., når de nuværende udgifter fratrækkes. 3.2 Afhentningsordninger på Fyn. Regionens arbejdsgruppe vedr. laboratorieservice til de praktiserende læger har på baggrund af en vurderng af transportordningerne på Fyn foreslået, at der af hensyn til den præanalytiske kvalitet skal der etableres en henteordning på Fyn, jfr. den videnskabelige artikel (bilag 1). En afhentningsordning foreslås etableret gældende for alle praksis på Fyn. Ordningen kan etableres med 1 eller 2 daglige afhentninger. Der er udarbejdet forslag hertil, som omfatter 8 portørbiler, som afhenter i hvert sit distrikt (Bilag 2) enten én gang eller to gange dagligt. Forslagene baserer sig på beregninger fra Portørtjenesten på OUH. Beregninger bygger på en faktisk gennemkørsel af de forskellige ruter, hvor de 2 eksisterende depoter i Odense bibeholdes. Page 4 of 28

Det foreslås, at en henteordning varetages af sygehusenes personale. Hermed er der mulighed for at integrere samarbejde med sygehuslaboratorierne samt kørslen kan kombineres med anden sygehuskørsel. Fælles for begge ordninger er kravene til opbevaring, som for det første består i opbevaring i opretstående glas i racks, som passer til centrifugerne på sygehusene. Hertil kommer, at prøverne skal opbevares ved stuetemperatur, hvilket temperaturmæssigt ikke er et problem nedadtil, idet prøverne opbevares i klinikkernes stuetemperatur. I varme perioder med mere end 24-25 grader kan prøverne ikke opbevares i klinikkerne, hvorfor der kræves enten opbevaring i termoskab eller at der er aircondition i opbevaringslokalet. Sidstnævnte har en del praksis allerede installeret. Udgiften til sådanne foranstaltninger skønnes at være 3.000 5.000 kr. pr. praksis excl. moms., i alt ca. 0,8 1,0 mio. kr. En yderligere parameter ved fastlæggelse af en afhentningsordning er tidsfaktoren, idet den afprøvning Vejle og Fyns amter sammen har gennemført viser, at prøverne under ovennævnte temperaturforhold kan opbevares med opfyldelse af kvalitetskravene i 6-8 timer mellem prøverne tages og analysen af dem. For begge afhentningsordninger gælder, at sygehusene vil modtage blodprøverne senere end i dag, hvor de modtages på laboratorierne fordelt over dagen med de postforsendte først og de afhentede senere på dagen, men inden for normal arbejdstid. Med de foreslåede afhentningsordninger vil sygehusene helt eller delvist modtage prøverne efter kl. 16. Dette medfører behov for tidsforskydning af arbejdsopgaver omkring modtagelse, registrering, centrifugering og analyse af blodprøverne. Herved opstår behov for flytning af et antal medarbejderes arbejdstider, jfr. bilag 3. Merudgiften i den forbindelse er medtaget i oversigten nedenfor. I nedenstående oversigt er opregnet økonomien i de forskellige transportordninger, opdelt i de årlige driftsudgifter og anskaffelser. Page 5 of 28

Oversigt over økonomien i forskellige transportordninger, mio. kr. Rammeaftale/ Centrifugering Ny afhentningsordning Nuværende ordninger Årlige driftsudgifter 2 runder 1 runde Ydelser almen praksis, merpris 13,5 Forsendelse af emballage 0,5 0,5 Bilers drift (v. køb) 0,46 0,32 0,25 Chauffører 3,15 1,7 0,25 Forsikringer og vægtafgift 0,09 0,09 Kompensation til sygehusene 0,733 1,866 FynBus 0,55 I alt 14,0 4,5 4,0 1,55 Lægernes medfinansiering -0,25-0,25-0,25-0,25 Nettoudgift for regionen 13,75 4,25 3,75 1,3 Merudgift for regionen ved fratrækning af nuv. udgifter 12,45 2,95 2,45 0 Anskaffelser ved etablering Biler, køb og indretning 1,3 1,3 Termoskabe/aircondition i 200 praksis 1 1 Emballage Centrifuger I alt 0 2,3 2,3 0 3.2.1. Afhentning i praksis 1 gang dagligt. Prøvematerialet afhentes af 8 biler i praksis/opsamlingssteder mellem kl. 13 og hen ad kl. 16. Alle utensilier, bl.a. tom emballage fra sygehuslaboratorium til brug ved prøvetagning er inkluderet i transporten fra sygehus til praksis. Fordelene ved denne ordning knytter sig at analysekvaliteten kan opfyldes, dog ikke i helt samme omfang ved 1 daglig afhentning som ved 2 daglige afhentninger. Page 6 of 28

Hertil kommer en mindre samlet udgift, primært til aflønning af chauffører og til bildriften, skønsmæssigt 4,0 mio. kr. Sygehuse og praksis sparer portoudgifter til henholdsvis emballage og til forsendelse af prøver. Af ulemper kan nævnes, at praksis ikke kan modtage prøvesvar samme dag som prøven er taget. Akutte meget vigtige svar kan dog gives til lægevagten. 3.2.1. Afhentning i praksis 2 gange dagligt Prøvematerialet afhentes af 8 biler i praksis/opsamlingssteder mellem kl. 9 og 12 og igen mellem 13 og 16. Alle utensilier, bl.a. tom emballage fra sygehuslaboratorium til brug ved prøvetagning er inkluderet i transporten. Fordelene ved denne ordning knytter sig, at analysekvaliteten kan opfyldes og til at en større del af prøverne ankommer til laboratorierne inden for dagarbejdstiden. Hertil kommer en større samlet udgift, primært til aflønning af chauffører og til bildriften, skønsmæssigt 4,5 mio. kr. Af ulemper kan nævnes, at praksis ikke kan modtage prøvesvar samme dag, hvis blodprøven er hentet i den 2. afhentningsrunde. Akutte meget vigtige svar kan dog gives til lægevagten. 4. Konklusion. Det foreslås, at der i sygehusregi etableres en henteordning 2 gange dagligt for samtlige på Fyn. Det vil betyde en årlig merudgift på ca. 3 mio. kr. og en éngangsudgift på 2,3 mio. kr. Page 7 of 28

Bilag 1. Stability of heparin blood samples during transport based on defined pre-analytical quality goals Esther Jensen 1, Marta Stahl 2, Ivan Brandslund 2,4, Per Grinsted 1,3 1. Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark 2. Department of Clinical Biochemistry, Vejle Hospital, Vejle, Denmark 3. Division for General Practice, University of Southern Denmark, Odense, Denmark 4. Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark In short: stability of blood samples Key-words: pre-analytical conditions, storage time, storage temperature, transport of blood samples, quality goals Corresponding author Esther Jensen Department of Clinical Biochemistry Odense University Hospital DK-5000 Odense C, Denmark Phone: +45 65 41 28 65 Fax. +45 65 41 19 11 E-mail: Esther.Jensen@ouh.regionsyddanmark.dk Page 8 of 28

Abstract Background In many countries and especially in Scandinavia blood samples drawn in primary health care are sent to a hospital laboratory for analysis. The samples are exposed to various conditions regarding storage time, storage temperature and transport form. As these factors can have a severe impact on the quality of results, we wanted to study which combination of transport conditions could fulfil our pre-defined criteria for maximum allowable error. Methods Samples from 406 patients from nine general practitioners (GP) in two Danish counties were sent to two hospitals for analyses, during two periods (winter and summer). Transport conditions (mail, courier pick-up, or brought to hospital by public coach), storage time, storage temperature and centrifugation requirements were different in the two counties. Results were tested for deviation from a 0-sample, the blood sample taken, centrifuged and separated at doctor s office within 45-60 minutes. This sample was considered as the best estimate of a comparison value. Results The pre-set quality goals were fulfilled for all the investigated components for samples transported to hospital by courier either as whole blood or as on gel after centrifugation, as long as the samples were stored at 20-25 C and centrifuged/analysed within 5-6 hours. Four percent of the samples sent by mail had mismatched identity, probably due to plasma being transferred to a new tube. Conclusions Samples can be sent as unprocessed anticoagulated whole blood if the above mentioned conditions are met. There is no need for centrifugation in the primary sector. Neither mailing of samples with plasma on gel nor public transport by coach bus fulfil our analytical demands. Page 9 of 28

Introduction In Denmark with a population of 5.5 million, about 3 million blood samples are drawn each year in General Practice (GP) and sent to hospital laboratories for analyses. The transport logistics are different for various counties in Denmark. Samples (whole blood or plasma) are transported by mail, by hospital car, taxi, coach or private transport. In at least one county all these possibilities are used. Preanalytical factors also vary: the samples are drawn in tubes with or without separation gel, sent with or without centrifugation, or with centrifugation followed by plasma separation (1, 2). Some hospital laboratories keep the samples at constant temperature 21±1 C (1). Different brands of tubes are used. The pre-analytical conditions have a decisive impact on the final result and may lead to diagnostic mistakes. Sinclair (3) describes seasonal pseudohyperkalaemia during transport of samples. A recent BMJ paper (4) deals with spurious hyperkalaemia caused by storage of the sample and transport conditions. Centrifugation of blood samples before transport is time consuming and expensive. Furthermore, transfer of plasma to another tube increases both the risk of sample mismatch and infection. Therefore it is preferable to transport whole blood. As both the economical and quality consequences of pre-analytical solutions are considerable, our aim was to investigate which combination of storage time, storage temperature and transport method would allow the use of primary tubes with whole blood or on gel after centrifugation. All existing procedures in the two counties were investigated. The focus was on combinations of transport conditions as such and not on a single factor. Materials and Methods Subjects Adult patients that were undergoing routine venous puncture at their GP were asked to participate. Extra tubes (6 or 7) were drawn and submitted to different pre-analytical conditions. The sample handling and the pre-analytical procedures were done by the GP s staff, nurses, secretaries or laboratory technologists. In Centre A four GP s recruited a total of 101 patients during March 2006 and 105 patients during August 2006. The samples were drawn between 8.00 and 9.30 a.m. In Centre B five primary health care centres each drew samples from 20 patients (a total of 100 patients) in April 2006 and from 100 patients in September 2006. Transport The centres existing transportation means were examined. For study purposes some additional situations were investigated. Centre A: Transport by coach: The samples were placed in Styrofoamtransport boxes. They were delivered in special boxes located at bus stops and were picked up by a public bus driver who delivered them to hospital porters. The samples transported this way were positioned randomly and exposed to outdoor temperatures for about 30 minutes. The duration of the transport was about 60 minutes. Transport by courier: The samples were collected at the primary care centre. These samples were placed in racks and were positioned up-right. The duration of the transport was about 10-60 minutes. The samples were collected from the GP s twice a day. Page 10 of 28

Transport by mail: Samples were sent after centrifugation, with plasma on gel. They normally reached the hospital the next morning. Samples were transported in a random position. The exposure to outdoor temperature was variable. Centre B: There is an established routine courier service, which picks up the blood samples within 8 hours after sampling. In the meantime all samples are stored at controlled temperature 21±1 C in a special thermostated box, and the stable temperature is maintained during the transport. During the transport the samples are positioned up right. This procedure is a follow-up of the results of the previous investigation described in 2005 (1). Duration of transport during this investigation was 10-15 minutes. As an additional transport form we investigated the stability of samples stored for 4 and 8 hours at room temperature. These samples were transported together and in the same way as the thermostated samples. Another possibility for GP s located far from Centre s B laboratory is to centrifuge the blood samples, transfer the plasma to another tube and mail them to the laboratory. Here an additional situation was tried: mailing of centrifuged samples on gel without plasma separation. Temperature Centre A: The average temperature for the period in which the samples were collected during the winter was - 4.3 º C at night and 1.5 º C during the day. In August average temperatures was above 30º C during the investigation. The GP s that participated had no air-conditioning. Centre B: Samples were stored either at room temperature or at 21 ± 1 C in the special thermostated boxes for 4 or 8 hours. The average temperature for the period in which the samples were sent by mail during winter was +1ºC at night and 5.0º during the day. In the summer period the average night temperature was 13 C and 20 C during the day. The sampling time, the arrival of the sample at the hospital and the analysing time were recorded in the laboratory information system. Abbreviations The investigated combinations of pre-analytical circumstances are designated A1 to A7 and B1 to B6 for Centre A and Centre B respectively. Explanation of these codes is given in Table 2 Analytical methods The GP s in Centre A used VenoSafe Lithium Heparin gel tubes (Lot 0510051) from Terumo Medical Incorporation, Europe. In Centre B Lithium Heparin tubes with gel from Beckton Dickinson, BD Diagnostics were used. All involved participants centrifuged the samples for 7 10 min. at 1300 2000 g according to tube manufacturer instructions. Page 11 of 28

The investigated components are listed in the Table 1. The inclusion criterion was that all components could be analysed in a single tube. Thus components such as glucose demanding a special blood sampling tube were not considered. Plasma concentrations of all investigated components were analysed in both centres on Modular P from Roche Diagnostics, with the commercial kits from Roche Diagnostics GmbH, Mannheim, Germany. 0 sample was the blood sample taken, centrifuged and separated at the doctors office within 45-60 minutes and considered as the best estimate of a true comparison value. Thereafter the plasma is considered stable during the designed protocol period (5-7). The 0 samples were handled by laboratory (Temperature regulated = thermostated) boxes, able to keep temperature 21±1 C were purchased from ViboCold, Denmark Analytical quality demands Limits for acceptable deviation from the 0-sample results were pre-defined by the authors of this paper (Table 1). CLIA rules (as cited in Tietz, 8) and the relevance of the components for the GP s were taken into consideration. Since the analytical CV% for the single component in the laboratories influences both the comparison sample 0 and the transported samples and because the biological and sampling variations are eliminated as samples are taken in the same puncture, the total acceptable difference was defined as follows: SD 2 Total acceptable deviation = SD 2 2 Acceptable pre-analytical deviation + 2 x SD analytical The quality demand was that at least 95% of the measurements had to be within 2 SD Total deviation from the 0-sample. {Table 1} Outliers: The 0-sample results were checked by Burnetts model (9) and none was found. Outliers for the single test sample were not excluded and the sample was not re-analysed. Statistics The number of results exceeding quality limits for the single transport form was tested for significance against transport form B1, where the demands were met, by help of Fisher s exact chi-square test. Ethics The study was presented to and accepted by the Regional Danish Science Ethics Committee as a technical and quality investigation. Oral informed consent was obtained from all participants. Results {Table 2} Table 2 shows how the components were affected by transport and the percentage of results fulfilling quality demands. The most sensitive components were Potassium, Phosphate, ALT, GGT, and LD, especially if specimens were exposed to high temperatures during the summer period (A2, A7, B5). Page 12 of 28

Potassium stability is strongly influenced by prolonged storage times and temperature (A3, A4, A6, A7, B3- B5). Phosphate represents a serious problem for almost all combinations of time and temperature (A2, -A7 and B2 - B6). Analysis shows that these transport forms give results that differ significantly from those obtained under the optimal transport and storage combination B1(whole blood, thermostated storage for max. 6 hours, courier transport (see Table 3). ALT, GGT and LD cannot be transported by coach or sent by mail on gel (A2, A7, B4 and B5). There are also minor deviations for some other components, especially for samples transported by couch or sent by mail on gel. {Table 3} Table 3 summarizes the evaluation of the different ways of transport of tubes. Results are arranged from the highest to the lowest degree of fulfilment of quality demands in the winter and in the summer periods, separately and also totally, transport form B1 yielding the best sample quality. It can be seen that all components in transport form B1 fulfil quality demands. All other transport forms produce several results falling outside acceptance limits and they are all of worse quality than transport form B1 (A5 against B1 tested with Fisher s exact Π 2 test is statistically significant P = 0. 014, all others P < 0.00005). {Table 4} Table 4 is the opposite of Table 2 and shows what the acceptance limits should be if 95% of the results were to fall within these limits in summer as well as in winter. Discussion Several papers (10-13) describe influences of different pre-analytical factors on stability of the blood samples. Each factor and its effect have been examined separately and exhaustively. In contrast to analytical quality goals, pre-analytical quality goals are seldom defined and no standards seem to be available. Ideally pre-analytical variation should be included in the goal for total analytical error. This article differs from other papers investigating pre-analytical influence on laboratory results as this is not a descriptive paper listing various factors e.g. manufacturer of sampling tubes, time, temperature and centrifugation and their influence on results. Our present investigation was directed towards establishing practical, real-life circumstances for storage and transport preserving sample quality for all investigated components. It would be very confusing if blood samples for analysing some components could be sent in one transport form but not in another. The other important point was that the impact of the single factor was not investigated. The potential effects of single factors were not compared. Only the number of results exceeding limits was interesting. At first, we defined the acceptable error size as a deviation from the result obtained under optimal conditions. Secondly, we examined if the different ways the blood samples are transported influenced the results in relation to the pre-defined demands. Finally we ranked the different transport models according to their capability of giving 95% results within the stated limits. We investigated 13 combinations of transport, temperature and storage time. Page 13 of 28

The common transport characteristics fulfilling the demanded criteria for all investigated components (except Phosphate) were in both centres that the samples were stored at 20-25 o C, transported by courier in a stable, up-right position and centrifuged not later than 6 hours after sampling (Table 2). All other transport forms demonstrate problems. Transport of plasma on gel by public coach or by mail (A2, A4, A7, B5) and exposing the specimens to random positions and extreme temperatures invalidate results for some of the components. The most sensitive components were Potassium, Phosphate, ALT, GGT, and LD. (Table 2) Potassium analyses are frequently requested because of its clinical applicability. Doctors are aware of its vulnerability and thus there is a focus on Potassium (3, 4, 14). Table 2 shows as expected that temperature and duration of storage play a crucial role for its stability. Deviations were observed both in winter and summer, depending on storage temperature. But even if the samples were stored and transported at optimal, stable temperature, Potassium concentrations increased, if the samples were stored longer than 6 hours (B3). Plasma samples transferred to another tube can be sent by mail (B6) with the exception of Phosphate (see below). Phosphate represents, surprisingly, a serious problem for many combinations of time and temperature even if the plasma is separated (Table 3, summer). Even the results for Phosphate transported by mail on gel after centrifugation deviated modestly from the 0 value (A7 and B5). Samples for Phosphate estimation should be taken in a hospital. ALT, GGT and LD should not be transported by coach or sent by mail on gel. Additional experiments in Centre A demonstrated that shaking of tubes leads to gel fragmentation, which may be a reason for the lower values for ALT after transport with coach or by mail on gel (data not shown). Regarding LD haemolysis was observed in some samples, probably due to shaking under the transport. As previously mentioned we were not interested in the reason for the poor outcome but rather in which transport circumstances preserved sample quality best. Percentage of results fulfilling or not fulfilling the defined demands, however, is not a crucial point. More interesting is the degree of deviation that could affect clinical conclusions. The seriousness of the deviations can be seen in Table 4 which shows how much the acceptable maximal deviation defined in Table 1 should be extended to ensure that 95% of the results would fulfil the demands. It can be seen (Table 4) that for some components the extended limits would result in unacceptably large deviations from 0-value and thus invalidate the utility of the involved transport form. If the potassium limits were extended from 10% to 14-16%, corresponding to 0.4-0.5 mmol/l, more results could be accepted for analysis according to CLIA demands of 0.5 mmol/l (8). But if the demand is that 95% of results should be within the limits, then the limits of acceptance should be extended to 16-18%. For ALT the demand that 95% of results fall within the limits would be fulfilled, if the new limits were to be extended from 24% to 30-40% depending on transport form. For GGT acceptable limits for change should be extended from 28% to 70-90%, if transported by coach or by mail on gel (A2, A7 and B5). Similar changes should be introduced for LD (A7 and B5) and Phosphate (A4, A6 and B4). On the other hand, for some components (Cholesterol, Creatinine, Urate) the limits could be narrowed, if the demands were based on the presented data. Page 14 of 28

The quality demands defined in this paper (Table 1) are based on actual analytical imprecision in Centre A and B and on a subjective estimation of clinical needs. It can be discussed if the limits are too strict or too loose, and if they should be moderated. If so, some transport forms could be acceptable for specimen transport from general practise to hospital laboratory. For example, US CLIA (8) demands are based on biological variation and differ from ours regarding several components, some of them are even wider. If we redefine our demands according to these wider limits more flexible combinations of transport forms would be possible. However, for Potassium, we find CLIA rules too wide, as hypokalaemia 2.7 3.0 mmol/l can easily be missed if a deviation of 0.5 mmol/l is accepted. Some practical aspects should be considered. The longest storage time possible for most components (excluding Potassium) is found to be 6-8 hours. The time of sample collection is therefore very important for both GPs and hospital laboratories. Doctors will probably not accept a courier service, if the pick-ups will not include samples taken from patients visiting doctors at the end of the day. On the other hand, the acceptable storage period of 8 hours will not leave enough time for the laboratory to do the analytical work. It should be emphasized that the time from blood sampling to analyses includes storage time at the general practitioners, collection by the courier, transport time, registration at the hospital laboratory and centrifugation. All these steps can prolong blood sample age and thus reduce its quality. We have formulated quality goals for performance of 21 biochemical components and observed what happens when blood samples were exposed to different pre-analytical conditions. Using these goals we were able to investigate different combinations of storage and transport conditions and conclude that short storage time, controlled temperature and treating the samples gently under transport should be preferred. We have decided in our region that blood samples should be picked up twice a day from GPs, which gives high patient safety and optimal user service while assuring the quality of the blood samples to be analysed. From a quality point of view the best transport form for most components has traditionally been considered to be the transport of plasma centrifuged and separated shortly after sampling. This transport form is expensive (compensation to doctors and for mailing), requires that all general practitioners have suitable centrifuges and also has labour requirements. The serious disadvantage is that transferring of plasma material to new tubes jeopardizes the advantages of closed sampling systems: safety regarding patient identification and reduced risk for contamination and infection. During the investigation period we registered identity mismatch for 4 patient samples out of 20 in one doctor s office. It happened for plasma, which was transferred to another tube after centrifugation. This investigation demonstrated that the degree of observed deviation from the defined demands depended markedly on chosen logistics, but also showed ways to solve the problems. In Centre B the transport form described as B1 was introduced 3 years ago. All general practices cooperating with the laboratory are equipped with thermostated boxes able to keep a constant temperature of 21± 1 C. Whole blood samples are stored in these boxes until they are picked-up by courier car service using the same type of thermo boxes. Conclusion The investigated components, representing a broad repertoire of most frequently requested analyses from GP, fulfil the quality demands, if whole blood samples are transported to the hospital laboratory by door to door courier service. This means that they are not exposed to temperatures beyond 20-25 C at any time, that they are protected from shaking and that the samples are centrifuged not later than 6 hours after the sampling. Consequently, there is no need for the centrifugation in primary sector if these conditions are satisfied. Page 15 of 28

If the storage /transport conditions are not optimised, biased results can be reported jeopardising safety, security and economy of patient management. In our region it saves money, as centrifugation of blood samples at GP s offices is twice as expensive as a courier service. Additionally, the recommended courier service allows for reporting patients results to the GP the same day the blood samples were taken. Samples sent via mail fulfil the quality goals only if plasma is separated. Samples mailed on gel do not fulfil the quality goals. Transferring of plasma is time demanding, expensive, can lead to sample mismatch and exposes the staff in primary care for contagious agents. Thus, we recommend that samples be collected by a courier service. In summary we recommend the following conditions assuring the best pre-analytical quality of blood samples transported from general practitioners offices to the hospital laboratory: - Primary tubes ensuring sample identity (reducing mismatch or infection risk). - Temperature between 20 and 25 C during both storage and transport. It can be achieved either by storage of samples in special thermostated boxes or by air conditioning in the GPs offices. - Collecting of whole blood samples twice a day eliminating the need for centrifugation of the samples in the primary sector.. - Transport by a reliable courier service (up-right position, thermostated boxes). - Time of storage without centrifugation: not longer than 6 hours. Acknowledgment This study was supported in part by grants from the Health Care Organisation of the Region of Southern Denmark. We are very grateful to laboratory technologist Nina Brøgger and Kirsten Wahl for great logistic and enthusiastic work collecting the blood samples. We appreciate the contribution of the primary health care centres Agertoft and Hansen, Bak and Hansen and Holsedore, Odense, Lægehus Nr Lyndelse, Vissenberg and Bellinge, and primary health care centres Lægehuset i Ørstedsgade, Vesterbrogade, Søndergade, Dæmningen, and Sønderåparken, Vejle for providing the samples. Dr. David Sherson is thanked for linguistic assistance. Page 16 of 28

References 1. Stahl M, Brandslund I. Controlled storage conditions prolong stability of biochemical components in whole blood. Clin Chem Lab Med. 2005;43(2):210-5. 2. Nybo M, Hansen AB, Pedersen B, Jørgensen PJ and Kristensen SR. Præanalytisk variation af P-Kalium-ion, stofkonc. Relevans for primærsektoren? Klinisk Biokemi i Norden: 2004;16:16-22. 3. Sinclair D, Briston P, Young R, Pepin N. Seasonal pseudohyperkalaemia.. J Clin Pathol 2003;56:385-8. 4. Smellie W.S.A. Spurious hyperkalaemia. British Medical Journal 2007; 334:693-5. 5. Guder WG; Narayanan S, Wisser H, Zawta. Samples: from the patient to the Laboratory. The impact of preanalytical variables on the quality of laboratory results. Git Verlag, Darmstadt 1996, ISBN 3-928865-22-6. 6. Heins M, Heil W, Withold W. Storage of serum or whole blood samples? Effects of time and temperature on 22 serum analytes.eur J Clin Chem Clin Biochem. 1995; 33(4):231-8. 7. Guder WG. Preanalytical factors and their influence on analytical quality specifications. Scand J Clin Lab Invest 1999 Nov; 59(7):545-9. 8. Linnet K, Boyd JC. Selection and analytical evaluation of methods with statistical techniques in Tietz textbook of clinical chemistry and molecular diagnostics, 4 th ed. 2006, chapter 14. 9. Burnett RW, Accurate Estimation of Standard Deviations for Quantitative Methods used in Clinical Chemistry. Clin Chem 1975; 21:1935-1938. 10. Felding P, Hyltoft Petersen P, Hørder M. The stability of blood, plasma and serum components during simulated transport. Scand J Clin Lab Invest 1981; 41:425-30. 11. Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 2006; 44(6):750-9. 12. Lippi G, Guidi G.C, Mattiuzzi C, Plebani M. Praenalytical variability: the dark side of the moon in laboratory testing. Chem Lab Med 2006; 44(4):358-365. 13. Dufour D.R. Professional practice in clinical chemistry: Pre-analytic variation, or: what causes abnormal results (beside disease). Ed. AACC 1999, chapter 1. 14. Seamark D, Backhouse S, Barber P, Hichens J, Salzmann M, Powell R Transport and temperature effects on measurement of serum and plasma potassium. J R Soc Med.1999; 92:339-41. Page 17 of 28

Table 1. Biochemical components, critical level and maximal deviation from 0-sample which can be accepted Component Critical level Clinical acceptable pre-analytical deviation conc. (=2 SD) CV% CV% analytical Total CV for deviation % Allowed deviation (%) between 0- sample and test sample 95.5% results within ±2 SD Alanintransaminase (ALT) U/L 70 ± 15 ± 10.7 4 ± 12.1 ± 24.2 Albumin, g/l 35 ± 3 ± 4.3 5 ± 8.3 ± 16.5 Alkaline phosphates, U/L 105 ± 20 ± 9.5 2.5 ± 10.2 ± 20.3 Bilirubin, µmol/l 20 ± 7 ± 17.5 3.5 ± 18.2 ± 36.4 Calcium (Ca) mmol/l 2.1 ± 0.1 ± 2.4 2 ± 3.7 ± 7.4 Cholesterol Total, mmol/l 5 ± 0.3 ± 3.0 2 ± 4.1 ± 8.2 Cobalamin (B12), pmol/l 150 ± 20 ± 6.7 5 ± 9.7 ± 19.4 C-Reactive protein (CRP) mg/l 20 ± 7 ± 17.5 2 ± 17.7 ± 35.5 Creatinine, µmol/l 100 ± 7 ± 3.5 3 ± 5.5 ± 11.0 Creatinkinase, U/L 150 ± 20 ± 6.7 3 ± 7.9 ± 15.8 Free T4, pmol/l 22 ± 2 ± 4.5 3 ± 6.2 ± 12.4 γ-glutamyltransferase (GGT) U/L 75 ± 20 ± 13.3 3 ± 14.0 ± 28.0 HDL-Cholesterol, mmol/l 1 ± 0.1 ± 5.0 3 ± 6.6 ± 13.1 Lactatdehydrogenase (LD), U/L 200 ± 35 ± 8.8 2 ± 9.2 ± 18.4 LDL-Cholesterol, mmol/l 3 ± 0.2 ± 3.3 2 ± 4.4 ± 8.7 Phosphate (P) mmol/l 0.8 ± 0.1 ± 6.3 2 ± 6.9 ± 13.7 Potassium (K) mmol/l 3 ± 0.3 ± 5.0 1 ± 5.2 ± 10.4 Sodium (Na) mmol/l 140 ± 7 ± 2.5 1 ± 2.9 ± 5.7 Thyreotropin (TSH,) mu/l 4 ± 0.3 ± 3.8 2.5 ± 5.2 ± 10.3 Triglyceride, mmol/l 2 ± 0.2 ± 5.0 2 ± 5.7 ± 11.5 Urate, mmol/l 0.25 ± 0.05 ± 10.0 2 ± 10.4 ± 20.8 Critical level is the level at which the maximal allowed deviation is defined. Clinical acceptable pre-analytical deviation (95% CI) is given as a concentration (= 2 SD) in reported units and as CV%. CV% analytical is the imprecision in the laboratories. Total CV for deviation is the combined CV-analytical for both 0-sample and the test sample and the CV% of accepted deviation. Maximal allowed deviation is the 95 % CI limits for difference between 0-sample and test sample which fulfil the demands at the critical level. Page 18 of 28

Table 2 Percentage of results within the limits for maximal acceptable deviation Winter Transport to Centre A Centre B Centre A+B Centrifugation at GP hospital GP hospital GP hospital GP Transport by Courier Coach Courier Coach Courier Mail Courier Mail whole Blood sample on gel whole blood on gel on gel whole blood on gel Pipetted blood Lowest temperature 10 C -1.7 C 10 C -1.7 C 10 C 10 C -8.6 C 21±1 C 21±1 C 21±1 C 21±1 C -3.0 C Time to centrigugation (mean), hours 3/4 3/4 6 6 3/4 8 3/4 4 8 4 Time to analysing (mean) hours 6 8 30 6 10 30 Number 50 51 50 51 101 101 100 100 100 100 100 100 Patient results allowable deviation Component % A-1 A-2 A-3 A-4 A-5 A-6 A-7 B-1 B-2 B-3 B-4 B-5 B-6 median range Alanintransaminase, U/L 24 100 86 98 100 99 99 94 98 98 100 99 91 99 23 13-84 Albumin, g/l 17 100 100 100 100 100 100 100 100 100 100 100 100 100 44 37-50 Alkaline phosphates, U/L 20 100 100 100 100 100 100 100 100 100 100 100 100 100 65 29-181 Bilirubin, µmol/l 36 100 100 98 100 99 99 100 100 100 100 100 100 99 9 4-31 Calcium, mmol/l 7 100 96 100 94 99 99 89 99 100 99 100 98 98 2.33 2.00-2.61 Cholesterol Total, mmol/l 8 100 100 100 98 100 100 100 99 99 97 98 100 100 5.1 3.3-8.6 Cobalamin (B 12 ), pmol/l 19 100 100 100 100 100 98 363 55-1400 C-Reactive protein, mg/l 36 100 100 100 100 100 100 100 100 100 100 100 100 100 <5 <5-93 Creatinine, µmol/l 11 100 98 100 100 100 100 100 100 100 100 100 100 99 86 67-160 Creatinkinase, U/L 16 100 96 100 100 100 98 100 100 99 100 100 98 99 82 22-555 Free T 4, pmol/l 12 99 100 100 99 97 96 16 11-26 γ-glutamyltransferase, U/L 28 100 75 100 100 100 100 68 100 100 100 100 74 100 32 11-552 HDL-Cholesterol, mmol/l* 13 100 100 100 100 100 100 100 100 100 100 100 100 99 1.64 0.94-3.3 Lactatdehydrogenase, U/L 18 100 80 100 96 98 100 13 98 96 98 86 0 99 144 73-425 LDL cholesterol, mmol/l 9 96 96 96 98 99 99 90 2.8 1.2-5.6 Phosphate, mmol/l 14 100 98 68 59 100 62 92 99 90 70 37 93 96 1.03 0.48-1.47 Potassium, mmol/l 10 98 96 98 90 99 93 87 97 98 88 94 73 100 3.9 2.9-5.5 Sodium, mmol/l 6 100 100 100 100 100 100 100 100 100 100 100 100 100 141 133-145 Triglyceride, mmol/l 12 99 100 100 100 100 100 99 98 97 98 97 94 99 1.23 0.41-11.78 TSH, mu/l 10 100 100 100 100 98 99 1.45 0.03-7.6 Urate, mmol/l 21 100 100 100 100 100 100 100 100 100 100 100 100 100 0.31 0.16-0.71 Page 19 of 28

Table 2 Summer Transport to Centre A Centre B Centre A+B Centrifugation at GP hospital GP hospital GP hospital GP Transport by Courier Coach Courier Coach Courier Mail Courier Mail whole Blood sample on gel whole blood on gel on gel whole blood on gel pipetted blood Highest temperature >30 C >30 C >30 C >30 C >30 C >30 C >30 C 21±1 C 26 C 21±1 C 26 C 26 C Time to centrigugation (mean) 3/4 3/4 6 6 3/4 8 3/4 4 8 4 Time to analysing (mean), hours 6 8 30 6 10 30 Number 51 54 51 54 105 105 100** Patient results Component allowable deviation % A-1 A-2 A-3 A-4 A-5 A-6 A-7 B-1 B-2 B-3 B-4 B-5 B-6 median range Alanintransaminase, U/L 24 96 80 94 96 96 97 75 98 98 98 98 97 98 23 5-111 Albumin, g/l 17 100 100 100 100 100 100 100 100 100 100 100 100 100 44 35-51 Alkaline phosphates, U/L 20 100 100 100 100 100 100 100 100 100 100 100 100 100 71 14-173 Bilirubin, µmol/l 36 90 100 96 98 99 99 98 100 100 100 100 100 94 9 4-103 Calcium, mmol/l 7 100 100 100 98 99 98 98 100 100 100 100 100 100 2.36 2.15-2.72 Cholesterol Total, mmol/l 8 100 98 100 91 100 99 98 100 99 99 99 100 98 5.2 2.6-9.0 Cobalamin (B 12 ), pmol/l 19 100 100 100 100 100 96 299 131-656 C-Reactive protein, mg/l 36 100 100 100 100 100 100 100 100 100 100 100 100 100 <5 <5-205 Creatinine, µmol/l 11 100 98 98 98 99 99 97 100 100 100 100 100 97 90 68-206 Creatinkinase, U/L 16 100 100 98 96 97 98 98 100 100 100 100 100 95 96 19-496 Free T 4, pmol/l 12 99 98 97 88 100 100 14 11-23 γ-glutamyltransferase, U/L 28 98 74 96 100 97 99 52 99 99 98 99 79 99 33 8-611 HDL-Cholesterol, mmol/l* 13 100 100 100 100 100 99 100 100 100 100 100 100 100 1.54 0.8-2.93 Lactatdehydrogenase, U/L 18 92 68 98 94 99 98 26 95 96 98 93 0 99 159 105-306 LDL cholesterol, mmol/l 9 98 94 98 94 94 95 79 100 100 99 99 100 96 2.8 1.3-6.3 Phosphate, mmol/l 14 96 94 69 40 99 56 97 96 67 60 27 97 80 1.03 0.62-1.75 Potassium, mmol/l 10 100 100 77 50 100 71 95 99 96 87 91 97 95 4.1 3.0-5.4 Sodium, mmol/l 6 100 100 100 100 100 100 100 100 100 100 100 100 100 140 134-146 Triglyceride, mmol/l 12 100 100 100 100 100 100 98 100 97 100 100 95 99 1.56 0.38-11.41 TSH, mu/l 10 96 95 98 97 95 92 1.3 0.03-4.7 Urate, mmol/l 21 100 100 100 100 100 100 100 100 100 100 100 100 100 0.32 0.15-0.68 *HDL-Cholesterol in winter, Centre B N = 83 ** Number N = 100 for all component, yet in the summer period only 78 samples were collected as B5 in Centre B The number indicates the percentage of results fulfilling the demands. Page 20 of 28

26.okt. 2007 Table 3 Transport form ranked according to the number of components not fulfilling the pre-defined demands. Results from winter, summer and over-all (total) are shown. Number of results not fulfilling quality demands in transport forms A1-A7 and B2-B6 were found statistically significant different (P<0.00005) from transport from B1. Mode Time to Centrifugation Sample Temperature, C Storage Transport Transport by Time to analyse Component Number results not fulfilling Winter Summer Total B1 4 h Whole Blood A5 ¾ h On gel A1 ¾ h On gel B6 App.4 h Plasma B2 B3 4 h 8 h Whole blood Whole blood 21 ± 1 21 ± 1 Courier 6 h All fulfil 0 0 0 w: 20-22 s: 25 - >30 w: 20-22 s: 25 - >30 Room temp. 20-26 Room temp. 20-26 Outdoor Courier 8 h LDL 1 6 7 Outdoor Courier 6 h Outdoor Mail 30 h LD Bilirubin Bilirubin TSH P 0 0 1 1 4 8 10 6 8 20 21 ± 1 Courier 6 h P 10 33 43 21 ± 1 21 ± 1 Courier 10 h K P 12 30 13 40 8 10 7 9 24 25 70 A6 8 h Whole blood w: 20-22 s: 25 - >30 Outdoor Courier 8 h K P 7 28 29 44 36 72 A3 6 h Whole blood w: 20-22 s: 25 - >30 Outdoor Courier 6 h ALT K P 2 2 32 6 23 31 8 25 63 B4 8 h Whole blood Room temp. 20-26 21 ± 1 Courier 10 h K LD P 6 14 63 9 7 73 15 21 136 A7 ¾ h On gel w: 20-22 s: 25 - >30 Outdoor Mail 30 h P Ca K ALT LDL GGT LD 8 11 13 6 10 32 87 3 2 5 25 21 48 74 11 13 18 31 31 80 161 B5 App.4 h On gel Room temp. 20-26 Outdoor Mail 30 h P Triglyceride ALT K GGT LD 7 6 9 27 26 100 3 5 3 3 21 100 10 11 12 30 47 200 A2 ¾ h On gel w: 20-22 s: 25 - >30 Outdoor Coach 6 h P LDL ALT GGT LD 2 4 14 25 20 6 6 20 26 32 8 10 34 51 52 A4 6 h Whole blood w: 20-22 s: 25 - >30 Outdoor Couch 6 h Ca LDL LD K P 6 2 4 10 41 2 6 6 50 60 8 8 10 60 101 Page 21 of 28

Region Syddanmark Dato: 22 oktober 2007 Praksisafdelingen Initialer: STH Table 4. Deviations from 0 sample which will allow 95% of the results to fulfil criteria (summer and winter) Limits at which 95% of the results will fulfill the de Transport to Centre A Centrifugation at GP hospital GP hospital GP Transport by Courier Coach Courier Coach Courier Mail Blood sample on gel whole blood on gel whole blood on gel wh Component allowable deviation % A-1 A-2 A-3 A-4 A-5 A-6 A-7 B-1 B-2 Alanintransaminase 24 14 42 22 21 20 17 35 17 14 Albumin 17 5 5 6 7 5 5 5 4 5 Alkaline phosphates 20 4 6 5 6 6 6 10 5 5 Bilirubin 36 25 20 25 20 25 23 23 17 13 Calcium 7 3 4 3 7 5 5 7 3 3 Cholesterol Total 8 5 6 4 8 6 6 6 5 5 Cobalamin (B 12) 19 7 11 C-Reactive protein 36 8 11 8 7 11 6 6 1 5 Creatinin 11 5 8 6 7 7 8 8 4 5 Creatinkinase 16 6 11 8 10 9 7 11 6 6 Free T 4 12 8 8 γ-glutamyltransferase 28 13 73 15 13 15 15 86 11 9 HDL-Cholesterol 13 4 7 4 8 6 7 7 7 8 Lactatdehydrogenase 18 12 48 8 17 13 9 102 22 18 LDL cholesterol 9 7 8 7 9 8 8 12 Phosphate 14 6 11 21 29 8 25 14 13 21 Potassium 10 5 8 12 19 5 15 12 10 10 Sodium 6 2 2 3 3 2 2 2 2 2 Triglyceride 12 4 6 5 5 5 6 9 7 8 TSH 10 9 10 Urate 21 3 5 5 5 5 5 5 4 4

Afdeling: Portørorganisationen Udarbejdet af: LK/VB/JB Journal nr.: E-mail: lars.kristensen@ouh.fyns-amt.dk Dato: 24. januar 2007 Telefon: 6541 3652 Bilag 2 Notat Transport af blodprøver fra almen praktiserende læger til OUH. LaboratorieKonsulentOrdning (LKO), Esther Jensen har forespurgt Portørorganisationen om muligheden for afhentning af prøver fra de almen praktiserende læger på Fyn til OUH. Prøven skal transporteres forsvarligt i UN godkendt emballage. I tilfælde af få prøver, hentes disse til bilen hvor de emballeres, og i tilfælde af mange prøver, byttes den fyldte emballage med en tom. Prøverne/emballagen transporteres til og fra den praktiserende læge i bil. For at sikre kvaliteten af en prøve, må der maksimalt gå 8 timer fra prøvetagning til analyse af prøven, hvilket kan løses ved daglige afhentninger. Endvidere skal temperaturen i bilen være højst 23 0, og helst 20 22 0. LKO har foreslået at Fyn m.m. inddeles i 8 ruter. Ruterne skal gennemkøres 2 gange dagligt på hverdage med sluttid på laboratoriet kl. 12.00 og 16.00. Ruternes længde og tidsforbrug er i første omgang fremkommet via Krak (www.krak.dk). Efterfølgende har Portørorganisationen gennemkørt 7 af de 8 ruter (den ene rute køres allerede på nuværende tidspunkt), dels for at se om det beregnede tids- og kørselsforbrug stemte overens med det faktiske og dels for at se på de eksisterende af/pålæsningsforhold. Rute Beregnet tid og kørselsforbrug via Krak Tidsforbrug Km. forbrug Faktisk tids og kørselsforbrug Tidsforbrug Km. forbrug Antal Praksis Forventet tidsforbrug inkl. af og pålæsning 1 2 t 20 m 99 2 t 11 m 106 17 3 t 02 m 2 2 t 49 m 120 2 t 09 m 137 13 2 t 48 m 3 1 t 56 m 116 2 t 20 m 119 12 2 t 56 m 4 110 2 t 02 m 118 16 2 t 50 m 5 A Køres sammen med 2 t 20 m 50 andre effekter 5 B 2 t 20 m 22 23

6 1 t 31 m 90 1 t 50 m 90 9 2 t 17 m 7 1 t 40 m 98 1 t 53 m 99 7 2 t 14 m 8 2 t 04 m 121 2 t 15 m 130 9 2 t 42 m Tabel 1: Tids- og kørselsforbrug. Årligt km forbrug: Antal km dagligt pr. bil (gennemsnit) 218 Antal km årligt pr bil (gennemsnit) 54.438 Der er beregnet 3 minutter pr. praksis til af- og pålæsning samt 30 minutters ophold på OUH til aflæsning. Disse beregninger medfører: 1. afhentning af prøver ved de praktiserende læger ca. kl. 09.00 med ankomst til OUH ca. kl. 12.00. 2. afhentning af prøver ved de praktiserende læger ca. kl. 13.00 med ankomst til OUH ca. kl. 16.00. 08.30 09.00 12.00 12.30-13.00 13.00 16.00-16.30 Chauffører starter ruten fra OUH Chauffører indsamler prøver fra de almen praktiserende læger Aflevering af prøver på OUH OUH Chauffører indsamler prøver fra de almen praktiserende læger Aflevering af prøver på OUH Tabel 2: Tider for afhentnings og ankomsttider Økonomi: Ruterne 1 8 bemandes dagligt fra kl. 08.30 til kl. 16.30. Det ugentlige timeforbrug er 40 timer pr. rute, dvs. samlet tidsforbrug 320 nettotimer I personer: Samlet netto driftspersoner i alt 8,65. Samlet brutto driftspersoner i alt 10,81 Forudsætninger for beregningerne: Køb eller leasing af 8 stk. biler. Der er taget udgangspunkt i Fiat Doubló 1,9 pga. gode ind/udstigningsforhold, rummeligt varerum, døre i begge sider og klimaanlæg. Ny pris 122.500 kr., restværdi efter 4 år 15.000 kr. Uniformer til medarbejder. Mobiltelefon til bilerne (8 stk.) Kørsel i ugens 5 hverdage. 24